- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Latent Variable.
Displaying page 1 of 1.
EudraCT Number: 2016-002000-31 | Sponsor Protocol Number: FSJD-ISON-2016 | Start Date*: 2016-09-21 |
Sponsor Name:FUNDACIÓ SANT JOAN DE DÉU | ||
Full Title: Open clinical trial phase IIa to study the isoniazid suspension absoption of 10mg/ml for the tuberculosis infection treatment in patients under the age of 6 | ||
Medical condition: tuberculosis infection in patients under the age of 6 | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000899-40 | Sponsor Protocol Number: Guid/05/Met-GDM/001 | Start Date*: 2006-08-28 | |||||||||||
Sponsor Name:GUIDOTTI | |||||||||||||
Full Title: ASSESSMENT OF EFFECTS OF A 12-MONTH TREATMENT WITH METFORMIN ON INSULIN ACTION AND SECRETION IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS (GDM) | |||||||||||||
Medical condition: previous gestational diabetes (GDM) and altered glucose metabolism in the post-partum period (Impaired Fasting Glucose or Impaired Gluocse Tolerance) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004602-25 | Sponsor Protocol Number: M04-716 | Start Date*: 2005-06-30 |
Sponsor Name:Abbott GmbH & Co. KG | ||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind,Double-Dummy, Placebo-Controlled StudyComparing the Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects withModerate to Severe... | ||
Medical condition: Psoriasis Disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) BE (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005645-20 | Sponsor Protocol Number: A3921082 | Start Date*: 2013-06-25 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, 10017 | |||||||||||||
Full Title: A PHASE 2B, MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY, SAFETY, LOCAL TOLERABILITY AND PHARMACOKINETICS OF 2 DOSE STRENGTHS AND 2 REGIMENS OF TOF... | |||||||||||||
Medical condition: Chronic Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004139-31 | Sponsor Protocol Number: M06-810 | Start Date*: 2007-04-03 | |||||||||||
Sponsor Name:Abbott GmbH & Co. KG | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Period, Double − Blind Study to Determine the Optimal Protocol for Treatment Initiation with Methotrexate and Adalimumab Combination Therapy in Patients with Early... | |||||||||||||
Medical condition: Rheumatoid Arthritis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) SK (Completed) ES (Completed) AT (Completed) FR (Completed) SE (Completed) CZ (Completed) DE (Completed) NL (Completed) HU (Completed) NO (Completed) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002018-29 | Sponsor Protocol Number: A3921165 | Start Date*: 2020-12-09 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (sJIA) WITH ACTIVE SYSTEMIC FEATURES IN CHILDREN AND ADOLESCENT SUBJECTS | |||||||||||||
Medical condition: Systemic Juvenile Idiopathic Arthritis (sJIA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) PL (Completed) DE (Completed) BE (Completed) IT (Ongoing) NL (Prematurely Ended) SE (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020002-15 | Sponsor Protocol Number: A3921061 | Start Date*: 2010-11-15 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 3, MULTI-SITE, OPEN-LABEL STUDY OF THE LONG TERM SAFETY AND TOLERABILITY OF 2 ORAL DOSES OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS | |||||||||||||
Medical condition: Moderate To Severe Chronic Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) DE (Completed) GB (Completed) NL (Completed) FI (Prematurely Ended) ES (Completed) DK (Prematurely Ended) SE (Prematurely Ended) BG (Prematurely Ended) SK (Prematurely Ended) HU (Prematurely Ended) AT (Completed) GR (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001438-46 | Sponsor Protocol Number: A3921104 | Start Date*: 2018-03-27 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS | |||||||||||||
Medical condition: JUVENILE IDIOPATHIC ARTHRITIS (JIA) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011719-19 | Sponsor Protocol Number: AS001 | Start Date*: 2010-03-29 | ||||||||||||||||
Sponsor Name:SCHWARZ BIOSCIENCES, GmbH, A Member of the UCB Group of Companies | ||||||||||||||||||
Full Title: PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL IN SUBJECTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS (AXIAL SPA) | ||||||||||||||||||
Medical condition: axial spondyloarthritis (axial SpA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (Completed) HU (Completed) BE (Completed) IT (Completed) NL (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-013758-33 | Sponsor Protocol Number: RA0028 | Start Date*: 2010-06-17 | |||||||||||
Sponsor Name:UCB Pharma S.A. | |||||||||||||
Full Title: MULTICENTER STUDY WITH A 16-WEEK DOUBLE-BLIND, PLACEBO-CONTROLLED (DURING THE INITIAL 2 WEEKS) RANDOMIZED PERIOD, FOLLOWED BY A 24-WEEK OPEN LABEL EXTENSION TO ASSESS MAGNETIC RESONANCE IMAGE-VERIF... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000747-11 | Sponsor Protocol Number: GP17-301 | Start Date*: 2013-11-25 | |||||||||||
Sponsor Name:Hexal AG | |||||||||||||
Full Title: A randomized, double-blind, multicenter study to demonstrate equivalent efficacy and to compare safety and immunogenicity of a biosimilar adalimumab (GP2017) and Humira® in patients with moderate t... | |||||||||||||
Medical condition: Moderate to severe chronic plaque-type psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) SK (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001476-11 | Sponsor Protocol Number: AL002-2 | Start Date*: 2020-11-12 | |||||||||||
Sponsor Name:Alector Inc. | |||||||||||||
Full Title: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AL002 IN PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE | |||||||||||||
Medical condition: Early Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) PL (Ongoing) DE (Ongoing) IT (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.